Upstream Bio to Participate in Upcoming March Investor Conferences Feb 25, 2026 07:00AM
Upstream Bio (UPB) data was positive but not 'home run', says TD Cowen Feb 11, 2026 08:55AM
TD Cowen Reiterates Buy Rating on Upstream Bio (UPB) Feb 5, 2026 05:42AM
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Nov 5, 2025 07:00AM
Upstream Bio to Participate in Upcoming November Investor Conferences Oct 31, 2025 07:00AM


Feb 25, 2025 08:00AM Upstream Bio to Present at Upcoming March Investor Conferences
Nov 7, 2024 07:00AM Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Nov 5, 2024 05:30AM TD Cowen Starts Upstream Bio (UPB) at Buy
Oct 15, 2024 04:15PM Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 11, 2024 06:02AM Upstream Bio (UPB) Prices Upsized 15M Share IPO at $17/sh
Oct 10, 2024 07:35PM Upstream Bio Announces Pricing of Upsized Initial Public Offering
Sep 18, 2024 04:09PM Upstream Bio (UPB) Files for Proposed IPO